Russell Frank Company’s Alder Biopharmaceuticals ALDR Stock Holding History

Russell Frank Company’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,854	Closed	-$97K	–	3084
2015 Q4	$97K	Sell	2,854 -11,148	-80%	-$377K	﹤0.01%	2807
2015 Q3	$459K	Sell	14,002 -5,499	-28%	-$234K	﹤0.01%	2497
2015 Q2	$1.03M	Sell	19,501 -10,947	-36%	-$398K	﹤0.01%	2300
2015 Q1	$879K	Sell	30,448 -11,960	-28%	-$328K	﹤0.01%	2205
2014 Q4	$1.23M	Buy	+42,408	New	+$761K	﹤0.01%	2041

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Russell Frank Company's ALDR Position: Q1 2016 in Review

Russell Frank Company sold out of Alder Biopharmaceuticals (ALDR) in Q1 2016, closing a stake of 2,854 shares — an estimated $97K sold.

Russell Frank Company first reported a position in ALDR in Q4 2014 and held it in 5 quarters. The position peaked at $1.23M in Q4 2014. 117 funds tracked by Wall St. Rank hold ALDR as of Q1 2016.

Russell Frank Company reported no remaining Alder Biopharmaceuticals position as of Q1 2016 after selling out during the quarter.
Russell Frank Company sold 2,854 Alder Biopharmaceuticals shares in Q1 2016, an estimated $97K.
Russell Frank Company first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 5 quarters.
Russell Frank Company's Alder Biopharmaceuticals position peaked at $1.23M in Q4 2014.
117 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.